Literature DB >> 28728932

The "Complex Restrictive" Pulmonary Function Pattern: Clinical and Radiologic Analysis of a Common but Previously Undescribed Restrictive Pattern.

Ryan D Clay1, Vivek N Iyer2, Dereddi Raja Reddy3, Brittany Siontis4, Paul D Scanlon2.   

Abstract

BACKGROUND: Most patients with restriction have a pulmonary function test (PFT) pattern in which total lung capacity (TLC), FVC, and FEV1 are reduced to a similar degree. This pattern is called "simple restriction" (SR). In contrast, we commonly observe a pattern in which FVC percent predicted (pp) is disproportionately reduced relative to TLCpp. This pattern is termed "complex restriction" (CR), and we attempted to characterize its clinical, radiologic, and physiologic features.
METHODS: This study reviewed PFT results of patients tested between November 2009 and June 2013 who had restriction (TLC less than the lower limit of normal). SR was defined as TLCpp-FVCpp ≤ 10%, and CR was stratified into four classes based on TLCpp-FVCpp discrepancy: Class 1 CR, TLCpp-FVCpp > 10% and ≤ 15%; Class 2 CR, TLCpp-FVCpp > 15% and ≤20%; Class 3 CR, TLCpp-FVCpp > 20% and ≤ 25%; and Class 4 CR, TLCpp-FVCpp > 25%. The medical records of 150 randomly selected patients with SR and 50 patients from each CR class were reviewed.
RESULTS: Of 39,277 PFTs completed, we identified 4,532 patients (11.5%) with restriction: 2,407 (6.1%) with SR, 1,614 (4.1%) with CR, and 511 (1.3%) with a mixed pattern. Patients with CR were younger, were more often women, and had a higher prevalence of neuromuscular disease, BMI > 40 kg/m2 or < 18.5 kg/m2, diaphragmatic dysfunction, bronchiectasis, CT mosaic attenuation, and pulmonary hypertension (P < .0001, < .0001, < .001, .004, .0008, .002, .008, .009, .053, and .01, respectively) and a lower prevalence of interstitial lung disease (P < .0001).
CONCLUSIONS: CR is a common PFT pattern with distinct clinical features. The associated clinical entities share impaired lung emptying (eg, neuromuscular disease, occult obstruction, chest wall limitation). Clinicians should be aware of this novel PFT pattern and how it shapes the differential diagnosis.
Copyright © 2017 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  PFT; physiology; pulmonary function testing; restrictive disorders

Mesh:

Year:  2017        PMID: 28728932     DOI: 10.1016/j.chest.2017.07.009

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  9 in total

1.  Multiple breath washout lung function reveals ventilation inhomogeneity unresponsive to mechanical assisted cough in patients with neuromuscular disease.

Authors:  Mathis Steindor; Anna Pichler; Laura Heitschmidt; Eva Pitsikoulis; Alexandra Kavvalou; Eser Orhan; Margerete Olivier; Florian Stehling
Journal:  BMC Pulm Med       Date:  2022-06-04       Impact factor: 3.320

2.  Physiological Criteria Are Useful for the Diagnosis of Idiopathic Pleuroparenchymal Fibroelastosis.

Authors:  Takato Ikeda; Yoshiaki Kinoshita; Yusuke Ueda; Tomoya Sasaki; Hisako Kushima; Hiroshi Ishii
Journal:  J Clin Med       Date:  2020-11-22       Impact factor: 4.241

3.  Non-invasive techniques to assess restrictive lung disease in workers exposed to free crystalline silica.

Authors:  Massimo Corradi; Giuseppina Folesani; Benedetta Robuschi; Luisella Selis; Maria Grazia Riccelli; Maria Grazia Riccelli; Roberta Andreoli; Roberta Pisi; Alfredo Chetta; Antonio Mutti
Journal:  Med Lav       Date:  2019-04-19       Impact factor: 1.275

4.  Severe and progressive platythorax disproportionate to lung fibrosis: A rare variant of idiopathic pleuroparenchymal fibroelastosis.

Authors:  Takato Ikeda; Yoshiaki Kinoshita; Yusuke Ueda; Tomoya Sasaki; Hisako Kushima; Hiroshi Ishii
Journal:  Respir Med Case Rep       Date:  2021-03-19

5.  Diagnosis and Management of Interstitial Lung Disease in Patients with Connective Tissue Diseases.

Authors:  Matthew Koslow; Mehrnaz Maleki-Fischbach; Rebecca C Keith
Journal:  Case Rep Rheumatol       Date:  2021-04-24

6.  Assessment of respiratory function and exercise tolerance at 4-6 months after COVID-19 infection in patients with pneumonia of different severity.

Authors:  Laura Pini; Rossano Montori; Jordan Giordani; Michele Guerini; Nicla Orzes; Manuela Ciarfaglia; Marianna Arici; Carlo Cappelli; Simone Piva; Nicola Latronico; Maria L Muiesan; Claudio Tantucci
Journal:  Intern Med J       Date:  2022-09-16       Impact factor: 2.611

7.  Lung function impairment in the German Lung Cancer Screening Intervention Study (LUSI): prevalence, symptoms, and associations with lung cancer risk, tumor histology and all-cause mortality.

Authors:  Rudolf Kaaks; Evangelia Christodoulou; Erna Motsch; Verena Katzke; Mark O Wielpütz; Hans-Ulrich Kauczor; Claus Peter Heussel; Monika Eichinger; Stefan Delorme
Journal:  Transl Lung Cancer Res       Date:  2022-09

8.  Trajectory of lung function to pleuroparenchymal fibroelastosis late after haematopoietic stem-cell transplantation.

Authors:  Giovanni Barisione; Alida Dominietto; Rita Bianchi; Alessandro Garlaschi; Andrea Bacigalupo; Lorenzo Stellino; Vito Brusasco
Journal:  Respir Med Case Rep       Date:  2019-07-27

9.  Low FVC/TLC in Preserved Ratio Impaired Spirometry (PRISm) is associated with features of and progression to obstructive lung disease.

Authors:  Spyridon Fortis; Alejandro Comellas; Victor Kim; Richard Casaburi; John E Hokanson; James D Crapo; Edwin K Silverman; Emily S Wan
Journal:  Sci Rep       Date:  2020-03-20       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.